The study is to evaluate tramadol ,dexmedetomedine and clonidine as an adjuvant to levobupivacaine in supraclavicular brachial plexus block

Phase 4

Not yet recruiting

• Conditions: Medical and Surgical, (2) ICD-10 Condition: 8||Other Procedures,

• Registration Number: CTRI/2022/11/047386
• Lead Sponsor: Jnu hospital

Brief Summary

The study is to evaluate tramadol ,dexmedetomedine and clonidine as an adjuvant to levobupivacaine in supraclavicular brachial plexus block in terms of

•Hemodynamic responses

•Onset of sensory blockade and motor blockade

•Duration of sensory and motor blockade

•To compare post operative pain levels.

•Complications / side effects if any

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-11-16
• Study Start: 2022-11-20

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patient who giving informed consent.

Exclusion Criteria

Patients with previous history or clinical presentation with central or peripheral neurological disease, coagulopathy, infection at the site of injection, patient allergic to any of the study drugs and those unable to co-operate will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of analgesic	Ramsay scale every 15 min interval
Intraoperative hemodynamic monitoring	Ramsay scale every 15 min interval

Secondary Outcome Measures

Name	Time	Method
Effect of three drugs .	•Hemodynamic responses

Trial Locations

Locations (1)

JNUIMSRC; 🇮🇳 Jaipur, RAJASTHAN, India

JNUIMSRC

🇮🇳Jaipur, RAJASTHAN, India

Dr S P Sharma

Principal investigator

9414293768

spsharmadr@yahoo.com